Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.

Simon, James A; Liu, James H; Speroff, Leon; Shumel, Brad S; Symons, James P

Simon, James A; Liu, James H; Speroff, Leon; Shumel, Brad S; Symons, James P.

Affiliation

Simon JA; Women's Health Research Center, Laurel, MD 20707, USA. jasimon@whrc.net

Am J Obstet Gynecol ; 188(1): 92-9, 2003 Jan.

Article in En | MEDLINE | ID: mdl-12548201

Subject(s)

Estrogens, Conjugated (USP)/administration & dosage; Medroxyprogesterone Acetate/administration & dosage; Norethindrone/analogs & derivatives; Norethindrone/administration & dosage; Postmenopause; Uterine Hemorrhage/prevention & control; Adult; Amenorrhea/epidemiology; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP)/adverse effects; Ethinyl Estradiol/administration & dosage; Ethinyl Estradiol/adverse effects; Female; Humans; Medroxyprogesterone Acetate/adverse effects; Middle Aged; Norethindrone/adverse effects; Norethindrone Acetate; Placebos; Time Factors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Uterine Hemorrhage / Medroxyprogesterone Acetate / Postmenopause / Estrogens, Conjugated (USP) / Norethindrone Type of study: Clinical_trials Limits: Adult / Female / Humans / Middle aged Language: En Journal: Am J Obstet Gynecol Year: 2003 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links